Phase
Condition
Schizotypal Personality Disorder (Spd)
Psychosis
Tourette's Syndrome
Treatment
N/AClinical Study ID
Ages 18-70 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Has a body mass index (BMI) of 18.0 - 40.0 kg/m^2
Meets criteria for the diagnosis of schizophrenia
Resides in a stable living situation when not hospitalized
Is willing and able to provide government-issued identification
Additional criteria may apply
Exclusion
Exclusion Criteria:
Has had a psychiatric hospitalization for more than 30 days during the 90 days beforescreening
Subject initiated first antipsychotic treatment within the past 12 months, or <1 yearhas elapsed since the initial onset of active-phase of schizophrenia symptoms
Subject poses a current suicide risk
Subject has a history of treatment resistance
Subject has a history of poor or inadequate response to treatment with olanzapine
Subject requires or has had electroconvulsive therapy (ECT) treatment in the 2-monthperiod prior to screening
Subject has a diagnosis of moderate or severe alcohol or drug use disorder
Subject has a positive urine drug screen for opioids, amphetamine/methamphetamine,phencyclidine, or cocaine at screening
Additional criteria may apply
Study Design
Connect with a study center
Alkermes Investigational Site
Burgas,
BulgariaSite Not Available
Alkermes Investigational Site
Kazanlak,
BulgariaSite Not Available
Alkermes Investigational Site
Lovech,
BulgariaSite Not Available
Alkermes Investigational Site
Novi Iskar,
BulgariaSite Not Available
Alkermes Investigational Site
Plovdiv,
BulgariaSite Not Available
Alkermes Investigational Site
Veliko Tarnovo,
BulgariaSite Not Available
Alkermes Investigational Site
Vratsa,
BulgariaSite Not Available
Alkermes Investigational Site
Belgrade,
SerbiaSite Not Available
Alkermes Investigational Site
Krabujevac,
SerbiaSite Not Available
Alkermes Investigational Site
Novi Knezevac,
SerbiaSite Not Available
Alkermes Investigational Site
Cherkasy,
UkraineSite Not Available
Alkermes Investigational Site
Kherson,
UkraineSite Not Available
Alkermes Investigational Site
Kiev,
UkraineSite Not Available
Alkermes Investigational Site
L'viv,
UkraineSite Not Available
Alkermes Investigational Site
Vinnytsia,
UkraineSite Not Available
Alkermes Investigational Site
Little Rock, Arkansas 72211
United StatesSite Not Available
Alkermes Investigational Site
Springdale, Arkansas 72764
United StatesSite Not Available
Alkermes Investigational Site
Culver City, California 90230
United StatesSite Not Available
Alkermes Investigational Site
Garden Grove, California 92845
United StatesSite Not Available
Alkermes Investigational Site
Lemon Grove, California 91945
United StatesSite Not Available
Alkermes Investigational Site
Long Beach, California 90822
United StatesSite Not Available
Alkermes Investigational Site
National City, California 91950
United StatesSite Not Available
Alkermes Investigational Site
Orange, California 92868
United StatesSite Not Available
Alkermes Investigational Site
San Diego, California 92103
United StatesSite Not Available
Alkermes Investigational Site
Washington, District of Columbia 20016
United StatesSite Not Available
Alkermes Investigational Site
Washington, D.C., District of Columbia 20016
United StatesSite Not Available
Alkermes Investigational Site
North Miami, Florida 33161
United StatesSite Not Available
Alkermes Investigational Site
Chicago, Illinois 60640
United StatesSite Not Available
Alkermes Investigational Site
Saint Louis, Missouri 63141
United StatesSite Not Available
Alkermes Investigational Site
St. Louis, Missouri 63141
United StatesSite Not Available
Alkermes Investigational Site
Las Vegas, Nevada 89102
United StatesSite Not Available
Alkermes Investigational Site
Marlton, New Jersey 08053
United StatesSite Not Available
Alkermes Investigational Site
Dayton, Ohio 45417
United StatesSite Not Available
Alkermes Investigational Site
Dallas, Texas 75243
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.